Henry Ford Health System:企業の戦略的SWOT分析

◆英語タイトル:Henry Ford Health System - Strategic SWOT Analysis Review
◆商品コード:GDPH24681SA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Henry Ford Health System – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Henry Ford Health System (HFHS) is a non-profit healthcare services entity, which provides acute, primary, tertiary, quaternary and preventive care services. The organization offers its services in the areas of cancer, dermatology, heart and vascular, lab services, neurology and neurosurgery, orthopaedics, primary care, radiology and imaging, urgent care, weight management and women’s health. HFHS operates through network of hospitals, medical centers and pharmacies. Its major hospitals comprise of Henry Ford Hospital; Henry Ford Macomb – Mt Clemens; Henry Ford Wyandotte Hospital; Henry Ford Allegiance Health; Henry Ford West Bloomfield Hospital; and Henry Ford Kingswood Hospital. The organization also offers community care services. HFHS is headquartered in Detroit, Michigan, the US.

Henry Ford Health System Key Recent Developments

Dec 10,2020: Henry Ford Health, Acadia Healthcare to build new facility in Michigan, US
Dec 07,2020: Henry Ford Health System receives $16 million gift to benefit Henry Ford Pancreatic Cancer Center
Aug 14,2020: Global Brand Leader to head Henry Ford Health System’s brand strategy and customer experience transformation
Aug 13,2020: HAP introduces innovative health plan for Michigan businesses in collaboration with Henry Ford Health System
Jun 30,2020: CarePort Health Platform shared by hospitals and post-acute care partners to ensure safe COVID-19 patient transitions

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Henry Ford Health System – Key Facts
Henry Ford Health System – Key Employees
Henry Ford Health System – Key Employee Biographies
Henry Ford Health System – Major Products and Services
Henry Ford Health System – History
Henry Ford Health System – Company Statement
Henry Ford Health System – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Henry Ford Health System – Business Description
Henry Ford Health System – SWOT Analysis
SWOT Analysis – Overview
Henry Ford Health System – Strengths
Henry Ford Health System – Weaknesses
Henry Ford Health System – Opportunities
Henry Ford Health System – Threats
Henry Ford Health System – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Henry Ford Health System, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Henry Ford Health System, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Henry Ford Health System, Recent Deals Summary
Section 4 – Company’s Recent Developments
Dec 10, 2020: Henry Ford Health, Acadia Healthcare to build new facility in Michigan, US
Dec 07, 2020: Henry Ford Health System receives $16 million gift to benefit Henry Ford Pancreatic Cancer Center
Aug 14, 2020: Global Brand Leader to head Henry Ford Health System’s brand strategy and customer experience transformation
Aug 13, 2020: HAP introduces innovative health plan for Michigan businesses in collaboration with Henry Ford Health System
Jun 30, 2020: CarePort Health Platform shared by hospitals and post-acute care partners to ensure safe COVID-19 patient transitions
Jun 04, 2020: Henry Ford Health System receives $266,000 grant from BET COVID-19 relief event through United Way for Southeastern Michigan
May 28, 2020: Henry Ford Health System welcomes new Senior Vice President and Chief Strategy Officer
Apr 28, 2020: Advaita Bioinformatics and Henry Ford Health System Discover that a Well-Known Drug Helps Prevent Worst COVID-19 Outcomes
Apr 13, 2020: Alternate care facility for Covid-19 patients opens in Michigan, US
Apr 02, 2020: Henry Ford Health System to lead national study to determine drug’s effectiveness in preventing COVID-19
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Henry Ford Health System, Key Facts
Henry Ford Health System, Key Employees
Henry Ford Health System, Key Employee Biographies
Henry Ford Health System, Major Products and Services
Henry Ford Health System, History
Henry Ford Health System, Other Locations
Henry Ford Health System, Subsidiaries
Henry Ford Health System, Key Competitors
Henry Ford Health System, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Henry Ford Health System, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Henry Ford Health System, Recent Deals Summary

★海外企業調査レポート[Henry Ford Health System:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Goldin Properties Holdings Ltd:企業の戦略・SWOT・財務情報
    Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Telormedix SA-製薬・医療分野:企業M&A・提携分析
    Summary Telormedix SA (Telormedix) is a biopharmaceutical company. The company develops and provides immune drugs for the treatment of cancer and other infectious diseases. It offers products such as TMX-201, TMX-202 and vesimune (TMX-101). Its vesimune (TMX-101) provides treatment for superficial b …
  • Ultra Electronics Holdings plc:企業のM&A・事業提携・投資動向
    Ultra Electronics Holdings plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ultra Electronics Holdings plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Dover Corporation:企業の戦略・SWOT・財務情報
    Dover Corporation - Strategy, SWOT and Corporate Finance Report Summary Dover Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Bioaster-製薬・医療分野:企業M&A・提携分析
    Summary Bioaster is a technology research institute that conducts research on infectious diseases and microbiology. The institute offers services in the therapeutic areas of respiratory diseases, diarrhea, AIDS and tuberculosis. Its technologies include biological sample collections, genomics and tr …
  • Simply Energy:企業の戦略的SWOT分析
    Simply Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Timberwest Forest Corporation:企業の戦略・SWOT・財務分析
    Timberwest Forest Corporation - Strategy, SWOT and Corporate Finance Report Summary Timberwest Forest Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sony Mobile Communications AB.:企業の戦略的SWOT分析
    Sony Mobile Communications AB. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Enel SpA (ENEL):企業の財務・戦略的SWOT分析
    Enel SpA (ENEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Hyposwiss Private Bank Geneve SA:企業の戦略・SWOT・財務情報
    Hyposwiss Private Bank Geneve SA - Strategy, SWOT and Corporate Finance Report Summary Hyposwiss Private Bank Geneve SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Semiconductor Manufacturing International Corporation:企業のM&A・事業提携・投資動向
    Semiconductor Manufacturing International Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Semiconductor Manufacturing International Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes busin …
  • FirstEnergy Corp:企業の発電所・SWOT分析2018
    FirstEnergy Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • PharmaLundensis AB:医療機器:M&Aディール及び事業提携情報
    Summary PharmaLundensis AB (PharmaLundensis) is a pharmaceutical company that develops drugs for lung diseases. The company develops drugs for chronic obstructive pulmonary disease (COPD), chronic bronchitis and influenza-induced lung failure. It also develops EcoFilter, a system that that eliminate …
  • Okklo Life Sciences BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Okklo Life Sciences BV (Okklo) is a biopharmaceutical company that develops novel therapeutic solutions. The company offers cyclodextrin-based medicines for the treatment of neglected and orphan diseases. It also develops therapeutics for infectious diseases and lysosomal storage diseases. O …
  • ERG SpA (ERG):電力:M&Aディール及び事業提携情報
    Summary ERG S.p.A. (ERG), a subsidiary of San Quirico S.P.A., is a diversified energy company. Through its subsidiaries, it conducts power generation through renewable and thermal sources. The company carries out the distribution and marketing of petroleum products and conducts refining activities. …
  • Humana Inc (HUM):企業の財務・戦略的SWOT分析
    Humana Inc (HUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Nuo Therapeutics Inc (AURX):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuo Therapeutics Inc (Nuo Therapeutics), formerly Cytomedix, is a biomedical company that specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. T …
  • Anhui Anke Biotechnology (Group) Co Ltd (300009):製薬・医療:M&Aディール及び事業提携情報
    Summary Anhui Anke Biotechnology (Group) Co Ltd (Anhui) is a developer, manufacturer and distributor of healthcare and pharmaceutical products. The company’s products include diagnostic products, genetic engineering products, polypeptide APIs, biochemistry products, precision medicine, synthetic med …
  • EuroSibEnergo Plc-エネルギー分野:企業M&A・提携分析
    Summary EuroSibEnergo PLC (EuroSibEnergo), a subsidiary of En+ Group is an energy company and producer of hydroelectric power. EuroSibEnergo generates, transmits and distributes electricity. It operations include extraction of coal, distribution and facilitating low cost operations. The company is e …
  • ABX Advanced Biochemical Compounds GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary ABX Advanced Biochemical Compounds GmbH (ABX), a subsidiary of Otsuka Holdings Co Ltd is a provider of biochemical compounds that manufactures, develops, and distributes biochemicals for nuclear medicine. The company provides products such as PET and SPECT precursors and reference standards, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆